Home

Charité Berlin Cancer research

Explora más en tu destino con GetYourGuide, la mejor web para reservar tours y actividades. Olvídate del estrés en tu viaje. Disfruta de cancelación fácil y atención al cliente 24/7 A platform for molecular oncology research. In 2006, and in an attempt to promote basic oncology research, Charité founded the Molecular Cancer Research As part of cancer research, we place special emphasis on the translation of scientific findings into the clinics for the development of novel therapies. This includes

Max SCHLAAK | Professor (Associate) | Charité

Tipos: Tours, Tours a pie, Tours en minibús, Visitas turística

You will be part of the CompCancer Research Training Group (RTG2424), which is a joint effort by Charité and Humboldt University of Berlin, in close cooperation

Charité - Universitätsmedizin Berlin. Open Menu Target audience - and local menus: Service. Back. Scientific focus. Research. Careers . Centre. Network. Go to Simón Méndez-Ferrer, National Cancer Research Institute, Madrid (ES) Daniel Peeper, Netherlands Cancer Institute, Amsterdam (NL) Dirk Schadendorf Charité - Universitätsmedizin Berlin. Open Menu Target audience - and local menus: Research Network of Zoonotic Infectious Diseases. About the research network

Charité - Descubre cosas que hace

Oncology: Charité - Universitätsmedizin Berli

  1. News from the Molecular Cancer Research Centre News from the centers 20.12.2009. Minisymposium 2009. News from the centers 03.12.2009. Winners of the MKFZ rising
  2. The Granada Lab seeks to develop tools to quantitatively understand the sources of heterogeneity in time and space within TNBC tumors. We are part of the translational
  3. Up-to-date news and information from around Charité - our hospital, research, and teaching. Go to Home page. Go to Menu. Go to Content. Meta menu: From here, you can
  4. Neuropathology: Dr. Josefine Radke, Department of Neuropathology, Charité - Universitätsmedizin Berlin CharitéCentrum für Frauen-, Kinder- und Jugendmedizin mit
  5. 1989-1992 Ph.D., University of Cambridge & Medical Research Council (MRC), Molecular Medicine Unit, UK 1992-1994 Postdoctoral research fellow, University of
  6. Franklin Hindenburgdamm 30 12203 Berlin Phone: +49 030 450 613 564 . Email: jan.kroenke@ charite.de

The new Research Training Group is headed by Prof. Dr. Nils Blüthgen of Charité - Universitätsmedizin Berlin. Over the past few years, we have witnessed a

Cancer Research MDC Berli

Auf dieser Seite finden Sie Wissenschaftsinformationen aus dem Charité Comprehensive Cancer Center (CCCC): zur ZeBank der Charité — Universitätsmedizin Berlin. zum CCCC als Host Institute der ESMO. zu Fortbildungen, Veranstaltungen und Kongressen auf dem Gebiet der Onkologie. Ausschreibungen und Preise auf dem Gebiet der Tumormedizin We are part of the Charité Comprehensive Cancer Center and the Berlin School of Integrative Oncology. The lab is located in the center of Berlin at the main campus of Charité - Universitätsmedizin Berlin, one of Europe's largest university hospitals. RESEARCH. The Granada Lab develops methods that combine long-term live single-cell microscopy with time series analysis, non-linear. Research. Careers. Network. Go to Charité-Portal. Lupe. CharitéCentrum für Tumormedizin (CC 14) Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie Charité Campus Benjamin Franklin Hindenburgdamm 30, D-12203 Berlin Special pages: Start Page. Search. Glossary. Legal Notices. Data protection. Media Center. Sitemap. Service functions: Facebook.. Instagram.. Twitter.. Contact. Share. Molekulare Tumorpathologie, Charité- Universitätsmedizin Berlin; Dr. Emmanuel Barillot Institut Curie Paris, Frankreich; Prof. Alfonso Valencia Spanish National Center for Cancer Research (CNIO) Madrid, Spanien; Prof. Lodewyk Wessels The Netherlands Cancer Institute, Amsterda

Cancer Research Charité - Universitätsmedizin Berlin The Berlin School of Integrative Oncology (BSIO) offers a structured 3-year doctoral program jointly educating basic scientists and physicians/medical students in the field of integrative oncology and features excellent research conditions, a comprehensive curriculum and a broad supervision and mentoring network Our research is carried out in accordance with the Charité Satzung der Charité A Study to Evaluate Different Decision-Making Approaches Used by Women Known to be at Increased Risk for Breast Cancer (DMP-1) Health Services Research. Epidemiologische Risiko-Scores als Instrumente des Wissenstransfers . Science Studies. Krankheitsvorstellungen und Krankheitserfahrungen von. On 2 September the Berlin Institute of Health at Charité (BIH) invites you to the inauguration of its new Administrative Director, Dr. Michael Frieser. Read more . 31 August 2021. Sarah Hedtrich is building organ models from human cells to study skin and lung diseases . Professor Sarah Hedtrich has been awarded the Johanna Quandt Professorship for Translational Human Organ Models at the.

Cancer research in low resource settings; Future Perspectives for Global Oncology in Academia; Preparation of assignments for the course ; Assessment Procedures: A written assignment (2000-3000 words, accounting 100% to the overall mark). The assignment assesses the capability of the student to analyse a real world situation and to translate the content of the module into public health. Research at the Institute of Microbiology - Charité Berlin . Lupe. You are here: Home. Research; Mission statement We, the scientists at the Institute of Microbiology aim to perform groundbreaking research into how multicellular organisms protect themselves against infections and how the commensal microbiota has established a mutualistic relationship with its host at border surfaces. An. Charité - Universitätsmedizin Berlin. Open Menu Target audience - and local menus: Research. Group Lutz Schomburg . About us. Studies. Careers. Network. Go to Charité-Portal. Working Group Prof. Dr. Lutz Schomburg. Lupe. You are here: Home. Research. Group Lutz Schomburg; Field of Research Selenium within the endocrine system - significance in therapy and prevention ; Thyronamins - a new. Neuropathology: Dr. Josefine Radke, Department of Neuropathology, Charité - Universitätsmedizin Berlin CharitéCentrum für Frauen-, Kinder- und Jugendmedizin mit Perinatalzentrum und Humangenetik (CC 17 Richard Koche, PhD, Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center. Wei Zhang, PhD, University of Massachusetts Boston, Center for Green Chemistry, College of Science and Mathematics . Prof. Dr. Johannes Schulte, Charité - Universitätsmedizin Berlin, Pediatric Hematology and Oncology . Dr. Sascha Sauer, Berlin Institute of Health (BIH) Genomics Facility. Prof. Dr.

Charité Comprehensive Cancer Center . Metanavigation: Hier finden Sie den Zugang zur Notfallseite, Kontaktinformationen, Barrierefreiheits-Einstellungen, die Sprachwahl und die Suchfunktion. Direkt zur Notfall-Seite. Charité kontaktieren: +49 30 450 564 222; E-Mail schreiben; Kontakt und Lageplan; Campus Charité MitteInvalidenstraße 80 / Virchowweg 23 10115 Berlin. Benutzerfreundlichkeit. Research. Back. 3D cell culture. Go to Charité-Portal. 3D cell culture Here you can find information about 3D cell culture, used as an in vitro model for cancer of the head and neck region. Lupe. You are here: Home. Research. Laboratory for Radiobiology and translational Radiation Oncology. 3D cell culture; What is denoted by the term 3D cell culture? One of the most important goals of.

Igor M. Sauer documents the scientific work of his group Experimental Surgery at the Charité - Universitätsmedizin Berlin Igor Maximilian Sauer is a transplant surgeon at the Department of Surgery, Charité Campus Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin (head: Prof. J. Pratschke). Beside his clinical work he is directing research in the field of Experimental. Research. Experimental methods in the Biofluid Mechanics Laboratory. Research projects Biofluid Mechanics. Novel probe for in vivo isolation of circulating tumor cells for the diagnosis and follow-up of cancer; Background The number of documented cancer cases is increasing worldwide. According to this study, one in five men and one in six women worldwide will be diagnosed with cancer during.

As part of this research program, a new generation of researchers will be developing computer-based tools for use in cancer research. The new Research Training Group is headed by Prof. Dr. Nils Blüthgen of Charité - Universitätsmedizin Berlin. Over the past few years, we have witnessed a paradigm shift within the field of cancer research, explains Prof. Blüthgen, Head of the. Embedded in the clinical and research network at the Charité Universitätsmedizin, our team's objective is to identify target structures of clinical and therapeutic relevance, and eventually initiate as well as conduct early phase clinical trials. We provide a platform for trial setups, by simulating therapeutic intervention in mice, identifying predictive and pharmacodynamic biomarkers. New PI strengthens exchange between MDC and Charité. MDC welcomes a new guest PI: Dr. Michael Sigal, a clinician scientist at Charité - Universitätsmedizin Berlin who studies how stem cells contribute to gastrointestinal disorders and cancer. He is excited to partner with MDC to explore the gut's interior lining on the single cell level Institute of Public Health (IPH, Charité) Charité Comprehensive Cancer Center (CCCC) Center for Stroke Research Berlin (CSB, Charité) Fördermittelgeber Bundesministerium für Bildung und Forschung (BMBF) Projektleitung Prof. Dr. phil. Liane Schenk. Leitung der Abteilung Medizinische und pflegerische Versorgungsforschung . CCM: Campus Charité Mitte. Kontakt aufnehmen; Prof. Dr. phil.

Go to Charité-Portal Systems pathology - Klauschen lab Our lab integrates histomorphology, genomics and proteomics techniques with novel computational approaches including image analysis, proteogenome bioinformatics and machine learning-based modeling to better understand tumor pathology and predict optimal precision therapies for cancer patients 3 Institute of Pathology, Charité-Universitätsmedizin Berlin, Berlin, Germany German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. 4 Eli Lilly and Company, Lilly Research Laboratories, Discovery Chemistry Research & Technologies, Alcobendas, Madrid, Spain. 5 Institute of Pathology, Medical University Graz, Graz, Austria. 6 German Cancer Consortium (DKTK. Charité - Universitätsmedizin Berlin Hindenburgdamm 30 12200 Berlin Tel: +49 30 8445 4468. E-Mail: stephan.mathas@ charite.de. University Education 1990-1997 Studies of Human Medicine at the Universität Köln; 2000 Dissertation at the Universität Köln; Professional Experience (selection) 1997- Resident at the Charité, Department of Hematology, Oncology and Tumor Immunology; 1999-2002.

Breast cancer - Charité - Universitätsmedizin Berli

  1. 15 Charité Universitätsmedizin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Tumour Immunology, Charitéplatz 1, 10117, Berlin, Germany; Charité - Universitätsmedizin, German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany
  2. The Charité - Universitätsmedizin Berlin is one of Europe's largest university hospitals, affiliated with Humboldt University and Free University Berlin. With numerous Collaborative Research Centres (CRC) of the Deutsche Forschungsgemeinschaft it is one of Germany's most research-intensive medical institutions. From 2012 to 2020, it was ranked by Focus as the best of over 1000 hospitals in.
  3. Researchers from Charité - Universitätsmedizin Berlin and the German Cancer Consortium (DKTK) have successfully solved a longstanding problem in the diagnosis of head and neck cancers. Working alongside colleagues from Technische Universität (TU) Berlin, the researchers used artificial intelligence to develop a new classification method which identifies the primary origins of cancerous.

The research team plans to study patients with bladder cancer and other cancers to establish whether cell therapy might be used to encourage and enhance the immune system's fight against the cancer. Photo: Hirscher/Charité. Press release by Charité and the Berlin Institute of Health In patients with bladder cancer, chemotherapy effectiveness is partially determined by the body's immune. HiDiH's major branch in Berlin is the Center for Digital Health at the Charité and the Berlin Institute of Health (BIH). In 2018, Roland Eils moved here from the German Cancer Research Center and the University of Heidelberg to found this new center in Germany's capital. HiDiH's smaller branch in Heidelberg is the Health Data Science Unit at Heidelberg University hospital. At both sites.

Research Group Sers - Charité - Universitätsmedizin Berli

In these efforts the MDC cooperates with the Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) as well as with national partners such as the German Center for Cardiovascular Research and numerous international research institutions. More than 1,600 staff and guests from nearly 60 countries work at the MDC, just under 1,300 of them in scientific research. The MDC. Affiliations 1 Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany

Projects: Medizinische Klinik mit Schwerpunkt Hämatologie

Center for Cardiovascular Research Charité Campus Mitte Hessische Straße 3-4, D-10115 Berlin Charité - Universitätsmedizin Berlin. Spezielle Seiten: Startseite. Suche. Glossar. Impressum. Intranet. Datenschutz. Presse. Sitemap. Barrierefreiheit. Service-Funktionen: Facebook.. Instagram.. Twitter.. Kontakt. Weiterempfehlen. Seite weiterempfehlen. Mit diesem Link können Sie die aktuell. Berlin has a lot going for it as a science city, Kienback enthuses, adding that the numerous universities and research institutes and the research hospital Charité produce many researchers that T-knife can recruit. San Francisco, she says, is the key to breaking into the U.S. market - but Kieback wants to enter the global market Katja HOFF · Cited by 6,165 | of Charité Universitätsmedizin Berlin, Berlin (Charité) · Read 122 publications · Contact Katja HOF

Prof

Researchers from Charité - Universitätsmedizin Berlin have developed a new diagnostic technique which enables the grading of tumor consistency using magnetic resonance imaging (MRI). The researchers used an imaging technique known as tomoelastography to visualize the mechanical properties of liver tumors. Results from this research have been published in Cancer Research*. Liver cancer is. Susen BUROCK | Cited by 640 | of Charité Universitätsmedizin Berlin, Berlin (Charité) | Read 46 publications | Contact Susen BUROC

Experimental Basic Research - CVK - Charit

  1. Group leader translational cancer research +49 30 450 536 047 +49 30 450 536 900; Contact us; CCM, Virchowweg 15 ; Charité - Universitätsmedizin Berlin Institute of Pathology (CCM/CVK) Charitéplatz 1 D-10117 Berlin. Campus / internal address: Virchowweg 15. Lupe. You are here: Home. Metas. Person-Detail; Page contents. Networking; Networking. Charité Comprehensive Cancer Center (CC 10)
  2. 1 Charité Universitätsmedizin Berlin, Institute of Pathology, Laboratory of Molecular Tumor Pathology and Systems Biology, Berlin, Germany. 2 Department of Hematology and Medical Oncology, Klinikum der Universität München (LMU); German Cancer Consortium site Munich (DKTK); German Cancer Research Centre (DKFZ), Heidelberg, Germany. 3 Department of Genetics/Epigenetics, FR8.3 Life Sciences.
  3. 2 Charité Comprehensive Cancer Center, Charitéplatz 1, 10117, Berlin, Germany. 3 German Cancer Research Center (DKFZ), Heidelberg, Germany. 4 Department of Immunology, Interfaculty Institute of Cell Biology, University of Tübingen, Tübingen, Germany. 5 Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tübingen, Tübingen, Germany. 6.
  4. 2012 - 2019 Mitglied der European Association for Cancer Research (EACR) Links. Research Gate. Forschungsprofil Expert*innenprofil 37 Publikationen. Vernetzung. Diagnostische und präventive Labormedizin (CC 5) Campus Charité Mitte (CCM) CharitéCentrum für Diagnostische und präventive Labormedizin (CC 5) Institut für Pathologie Charité Campus Mitte Charitéplatz 1, D-10117 Berlin.
  5. 12200 Berlin. Campus Charité MitteCharitéplatz 1 (Geländeadresse: Luisenstraße 64) 10117 Berlin. Benutzerfreundlichkeit: Kontraststärke Kontrastschalter. Schriftgröße. Schrift vergrößern: STRG + Schrift verkleinern: STRG-Sie können die Seite mithilfe Ihres Browsers größer oder kleiner anzeigen lassen. Verwenden Sie dafür bitte STRG + und STRG - . Mit STRG 0 gelangen Sie wieder zur.

Group Fuchs: Molecular Cancer Research Center (MKFZ

The Department of Medicine at Freie Universität Berlin and the Medical Faculty at Humboldt-Universität zu Berlin were united in a new joint corporation called Charité. The new organization includes all the areas of responsibility with regard to research and teaching in the fields of medicine and dentistry previously covered by the respective departments in the two universities The Charité - Universitätsmedizin Berlin and the German Cancer Research Center (DKFZ) jointly invite applications for the following position commencing as soon as possible Full Professorship (W2/W3) for Signaling-Based Precision Oncology Salary Group W2/W3 BBesG ÜfBE - tenure Research Methods - Concepts. PD Dr. Yanina Lenz with Dr. Fabian Dorra, PD Dr. Martin Schlaud, Dr. Jan Walter, Bayer Pharma AG. Research Methods - Analysis using R. Dr. Stefan Konigorski. Hasso-Plattner-Institute (HPI) Research Methods - Qualitative Research. Nicholas Alexander . Institute of Public Health (IPH), Charité - Universitätsmedizin Berlin. Epidemiology I. PD Dr. Linus Grabenhenrich. Carl WEIDINGER, Medical Doctor | Cited by 801 | of Charité Universitätsmedizin Berlin, Berlin (Charité) | Read 36 publications | Contact Carl WEIDINGE

We develop in silico models to predict the target landscape of small molecules relevant in cancer research and for other pharmaceutically relevant endpoints (cardiotoxicity, hepatotoxicity etc.). With an aim to serve the research community, we developed several bio- and cheminformatics databases and web servers (listed below). Using our knowledge base and toolchain, we analyze health care data. Patient-centered research. Lupe. Department for Women's Medicine - Charité - University Hospital Berlin . Women's Medicine at Charité - University Hospital Berlin consists of two organizational units, located in Berlin Wedding and Mitte. The Clinic for Gynecology is located at Berlin Wedding Campus Virchow-Klinikum. Professor Jalid Sehouli is Head of the Department and welcomes you on our. Am 2. September 2021 lädt das Berlin Institute of Health in der Charité (BIH) zum Amtsantritt seines neuen Administrativen Direktors Dr. Michael Frieser ein. Die feierlichen Grußworte sprechen. Zur Veranstaltung. Workshop QUEST Center. 06.09. - 09.09.2021 This CRC promotes translational research at the Charité. Our interventional radiology section provides targeted, minimally invasive local therapies for a variety of diseases ranging from vascular interventions (e.g., reopening of occluded vessels to restore blood flow) to local cancer treatment (e.g., ablation of liver tumors). Nine angiography units and ten inpatient beds are available for. Auf dieser Seite werden laufende und geplante klinische Studien von Wissenschaftlerinnen und Wissenschaftlern der Charité dargestellt, die diese im Internet präsentieren möchten. Falls Sie Interesse daran haben, an einer der präsentierten klinischen Studien teilzunehmen, können Sie mit der entsprechenden Klinik Kontakt aufnehmen

Die Organisation der Studie erfolgt in enger Zusammenarbeit mit den Friends of Cancer Research (FoCR), die eine gleichgerichtete Initiative in den USA betreuen. Unsere Arbeitsgruppe testet im Rahmen der Vergleichsstudie zwei unterschiedliche Assays (von den Firmen Thermo Fisher Scientific und Qiagen) auf einem Ion S5 XL Sequenziergerät. Erste Ergebnisse der Zusammenarbeit aller Teilnehmer. Campus Charité Mitte: Charitéplatz 1Geländeadresse: Luisenstr. 10 (Ebene 02, Raum 024) 10117 Berlin. Campus Virchow-Klinikum: Augustenburger Platz 1Geländeadresse: Südstraße 3 (EG, Raum 0.0056) 13353 Berlin. Campus Benjamin Franklin: Hindenburgdamm 30Haus V, Aufzug 13/14 (1. OG) 12203 Berlin. Benutzerfreundlichkeit: Kontraststärke Kontrastschalter. Schriftgröße. Schrift vergrößern. joerg.schulzke@charite.de: Phone direct: Phone Schulzke via secretary: +49 30 450-514531 +49 30 450-514522 : Secretary: Phone of secretary: Andreas Jantke andreas.jantke@charite.de +49 30 450-514522: FAX: +49 30 450-514962 : Representative of the German Research Foundation (DFG) at the Charité, Prof. Dr. Michael Fromm: Hints and advic

In our research group, we are characterising N-glycans, O-glycans and glycosaminoglycans in the context of health and disease. We aim at unraveling novel disease biomarkers and at the systematic characterization of biological mechanisms in human health. To this aim, we have optimized our workflow to analyse the glycome from isolated glycoproteins (IgG, alpha-1 antitrypsin, etc..), from cell. A team of researchers from Charité - Universitätsmedizin Berlin and the German Cancer Consortium (DKTK) has been able to trace the developmental trajectories of colorectal cancer cells. In. Während eines Forschungsaufenthalts in den USA am Memorial Sloan Kettering Cancer Center in New York (2013 bis 2016) spezialisierte er sich auf die DNA-Sequenzierung von Tumoren in Kindesalter. Im Jahr 2016 kam er nach Berlin, um im Clinician Scientist-Programm des Berlin Institute of Health in der Charité ( BIH ) und der Charité zu arbeiten Campus Charité MitteCharitéplatz 1 10117 Berlin. Campus Virchow-KlinikumAugustenburger Platz 1 13353 Berlin . Benutzerfreundlichkeit: Kontraststärke Kontrastschalter. Schriftgröße. Schrift vergrößern: STRG + Schrift verkleinern: STRG-Sie können die Seite mithilfe Ihres Browsers größer oder kleiner anzeigen lassen. Verwenden Sie dafür bitte STRG + und STRG - . Mit STRG 0 gelangen Sie.

Charité-Mayo-Conference 2019 - Berlin

Video: Charité Comprehensive Cancer Center - Charité

Tumorsphere Formulation and Use in Cancer Stem Cell Research

Cancer cells on the wrong path: Charité Mental Health

Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. IRI Life Sciences, Humboldt University of Berlin, Berlin, Germany . German Cancer Consortium (DKTK) Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany. These authors contributed equally to this work. Researchers at Charité - Universitätsmedizin Berlin and TU Berlin as well as the University of Oslo have developed a new tissue-section analysis system for diagnosing breast cancer based on.

Clinical studies of Charité: Charité - Universitätsmedizin

Nach 12 erfolgreichen Jahren der gemeinsamen Arbeit im Verbund wurde das Berlin-Brandenburger Centrum für Regenerative Therapien (BCRT) in Jahr 2019 verstetigt. Der Charité-Teil wurde in das Berlin Institute of Health (BIH) als eigener Forschungsschwerpunkt unter dem Namen BIH Center for Regenerative Therapies eingegliedert. Der Helmholtz-Teil konnte ebenfalls erfolgreich verstetigt w It works in close partnership with Charité - Universitätsmedizin Berlin in the jointly run Experimental and Clinical Research Center (ECRC), the Berlin Institute of Health (BIH) at Charité, and.

Research Intelligent ImagingMax HEILAND | Head of Department | CharitéPhotoacoustic Imaging Able to Visualize Deep Tissues

Affiliations 1 Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium, and German Cancer Research Center, Im Neuenheimer Feld, Heidelberg, Germany. Electronic address: cornelia.eckert@charite.de. 2 Children's Cancer Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health. Charité - Universitätsmedizin Berlin. image: The research team plans to study patients with bladder cancer and other cancers to establish whether cell therapy might be used to encourage and. In addition, the Charité established the Ruth Jeschke Travel Grant program to provide financial assistance and recognition to postdoctoral researchers (up to 3 years after graduation) working in the field(s) of tumor immunology and/or molecular cancer research who are participating in academic conferences, workshops or meetings